bmy cap 2010-2024

On December 31, Bristol-Myers Squibb (BMY) had a market capitalization of $109.8B, based on 2.04B shares at a price of $53.88.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
December 2024
$53.88
233,980,700
2,037,000,000
$109,757,022,900.00
November 2024
$56.42
236,127,100
2,037,000,000
$114,918,780,900.00
October 2024
$53.13
230,224,400
2,037,000,000
$108,223,976,700.00
September 2024
$48.74
233,391,200
2,031,000,000
$98,999,673,300.00
August 2024
$47.06
258,487,900
2,031,000,000
$95,574,594,900.00
July 2024
$44.81
381,178,300
2,031,000,000
$91,001,595,300.00
June 2024
$38.54
309,810,200
2,029,000,000
$78,196,442,600.00
May 2024
$38.13
317,062,000
2,029,000,000
$77,368,001,900.00
April 2024
$40.78
298,239,900
2,029,000,000
$82,734,301,100.00
March 2024
$49.75
415,074,300
2,023,000,000
$100,636,562,600.00
February 2024
$46.55
292,316,000
2,023,000,000
$94,178,742,000.00
January 2024
$44.83
321,935,900
2,023,000,000
$90,689,876,200.00
December 2023
$46.53
315,423,900
2,033,000,000
$94,590,814,100.00
November 2023
$44.78
297,138,600
2,033,000,000
$91,032,860,800.00
October 2023
$46.73
282,896,400
2,033,000,000
$94,996,397,600.00
September 2023
$52.10
234,207,900
2,064,000,000
$107,537,702,400.00
August 2023
$55.34
258,001,400
2,064,000,000
$114,226,507,200.00
July 2023
$55.83
183,970,500
2,064,000,000
$115,226,928,000.00
June 2023
$56.90
171,659,900
2,102,000,000
$119,606,742,800.00
May 2023
$57.34
196,527,200
2,102,000,000
$120,523,214,800.00
April 2023
$59.41
134,387,500
2,102,000,000
$124,881,081,200.00
March 2023
$61.17
186,870,500
2,113,000,000
$129,246,293,600.00
February 2023
$60.86
155,704,400
2,113,000,000
$128,593,587,900.00
January 2023
$64.11
164,845,300
2,113,000,000
$135,474,572,400.00
December 2022
$63.00
187,191,000
2,124,000,000
$133,809,026,400.00